Total: £ 56.28
Published Date: 2026-04-13 | Pages: 107 | Tables: 103 | Medical Care
The global Multiomics market was valued at US$ 3136 million in 2025 and is anticipated to reach US$ 6774 million by 2032, at a CAGR of 11.8% from 2026 to 2032.
Multiomics is a new approach where the data sets of different omic groups are combined during analysis. The different omic strategies employed during multiomics are genome, proteome, transcriptome, epigenome, and microbiome.
Single cell multiomics technologies typically measure multiple types of molecules from the same individual cell, allowing for more in-depth biological insight than can be gained by analyzing each molecular layer from separate cells. Single-cell multimodal omics (scMulti-omics) technologies allow for the measurement of multiple modalities from the same cell, including DNA methylation, chromatin accessibility, RNA expression, protein abundance, gene perturbation, and spatial information, unlike live-cell fluorescence imaging, which involves the destruction of cells for analysis.
This report delivers a comprehensive overview of the global Multiomics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Multiomics. The Multiomics market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Multiomics market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Multiomics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
BD
Thermo Fisher Scientific, Inc.
Illumina, Inc
Danaher (Beckman Coulter)
PerkinElmer, Inc
Shimadzu Corporation
Bruker
QIAGEN
Agilent Technologies, Inc.
BGI Genomics
Segment by Type
Single-cell Multiomics
Bulk Multiomics
Segment by Application
Cell Biology
Oncology
Neurology
Immunology
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Multiomics companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiomics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Single-cell Multiomics
1.2.3 Bulk Multiomics
1.3 Market by Application
1.3.1 Global Multiomics Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Cell Biology
1.3.3 Oncology
1.3.4 Neurology
1.3.5 Immunology
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Multiomics Market Perspective (2021–2032)
2.2 Global Multiomics Growth Trends by Region
2.2.1 Global Multiomics Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Multiomics Historic Market Size by Region (2021–2026)
2.2.3 Multiomics Forecasted Market Size by Region (2027–2032)
2.3 Multiomics Market Dynamics
2.3.1 Multiomics Industry Trends
2.3.2 Multiomics Market Drivers
2.3.3 Multiomics Market Challenges
2.3.4 Multiomics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Multiomics Players by Revenue
3.1.1 Global Top Multiomics Players by Revenue (2021–2026)
3.1.2 Global Multiomics Revenue Market Share by Players (2021–2026)
3.2 Global Top Multiomics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Multiomics Revenue
3.4 Global Multiomics Market Concentration Ratio
3.4.1 Global Multiomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiomics Revenue in 2025
3.5 Global Key Players of Multiomics Head Offices and Areas Served
3.6 Global Key Players of Multiomics, Products and Applications
3.7 Global Key Players of Multiomics, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Multiomics Breakdown Data by Type
4.1 Global Multiomics Historic Market Size by Type (2021–2026)
4.2 Global Multiomics Forecasted Market Size by Type (2027–2032)
5 Multiomics Breakdown Data by Application
5.1 Global Multiomics Historic Market Size by Application (2021–2026)
5.2 Global Multiomics Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Multiomics Market Size (2021–2032)
6.2 North America Multiomics Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Multiomics Market Size by Country (2021–2026)
6.4 North America Multiomics Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Multiomics Market Size (2021–2032)
7.2 Europe Multiomics Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Multiomics Market Size by Country (2021–2026)
7.4 Europe Multiomics Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Multiomics Market Size (2021–2032)
8.2 Asia-Pacific Multiomics Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Multiomics Market Size by Region (2021–2026)
8.4 Asia-Pacific Multiomics Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Multiomics Market Size (2021–2032)
9.2 Latin America Multiomics Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Multiomics Market Size by Country (2021–2026)
9.4 Latin America Multiomics Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Multiomics Market Size (2021–2032)
10.2 Middle East & Africa Multiomics Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Multiomics Market Size by Country (2021–2026)
10.4 Middle East & Africa Multiomics Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Details
11.1.2 BD Business Overview
11.1.3 BD Multiomics Introduction
11.1.4 BD Revenue in Multiomics Business (2021–2026)
11.1.5 BD Recent Development
11.2 Thermo Fisher Scientific, Inc.
11.2.1 Thermo Fisher Scientific, Inc. Company Details
11.2.2 Thermo Fisher Scientific, Inc. Business Overview
11.2.3 Thermo Fisher Scientific, Inc. Multiomics Introduction
11.2.4 Thermo Fisher Scientific, Inc. Revenue in Multiomics Business (2021–2026)
11.2.5 Thermo Fisher Scientific, Inc. Recent Development
11.3 Illumina, Inc
11.3.1 Illumina, Inc Company Details
11.3.2 Illumina, Inc Business Overview
11.3.3 Illumina, Inc Multiomics Introduction
11.3.4 Illumina, Inc Revenue in Multiomics Business (2021–2026)
11.3.5 Illumina, Inc Recent Development
11.4 Danaher (Beckman Coulter)
11.4.1 Danaher (Beckman Coulter) Company Details
11.4.2 Danaher (Beckman Coulter) Business Overview
11.4.3 Danaher (Beckman Coulter) Multiomics Introduction
11.4.4 Danaher (Beckman Coulter) Revenue in Multiomics Business (2021–2026)
11.4.5 Danaher (Beckman Coulter) Recent Development
11.5 PerkinElmer, Inc
11.5.1 PerkinElmer, Inc Company Details
11.5.2 PerkinElmer, Inc Business Overview
11.5.3 PerkinElmer, Inc Multiomics Introduction
11.5.4 PerkinElmer, Inc Revenue in Multiomics Business (2021–2026)
11.5.5 PerkinElmer, Inc Recent Development
11.6 Shimadzu Corporation
11.6.1 Shimadzu Corporation Company Details
11.6.2 Shimadzu Corporation Business Overview
11.6.3 Shimadzu Corporation Multiomics Introduction
11.6.4 Shimadzu Corporation Revenue in Multiomics Business (2021–2026)
11.6.5 Shimadzu Corporation Recent Development
11.7 Bruker
11.7.1 Bruker Company Details
11.7.2 Bruker Business Overview
11.7.3 Bruker Multiomics Introduction
11.7.4 Bruker Revenue in Multiomics Business (2021–2026)
11.7.5 Bruker Recent Development
11.8 QIAGEN
11.8.1 QIAGEN Company Details
11.8.2 QIAGEN Business Overview
11.8.3 QIAGEN Multiomics Introduction
11.8.4 QIAGEN Revenue in Multiomics Business (2021–2026)
11.8.5 QIAGEN Recent Development
11.9 Agilent Technologies, Inc.
11.9.1 Agilent Technologies, Inc. Company Details
11.9.2 Agilent Technologies, Inc. Business Overview
11.9.3 Agilent Technologies, Inc. Multiomics Introduction
11.9.4 Agilent Technologies, Inc. Revenue in Multiomics Business (2021–2026)
11.9.5 Agilent Technologies, Inc. Recent Development
11.10 BGI Genomics
11.10.1 BGI Genomics Company Details
11.10.2 BGI Genomics Business Overview
11.10.3 BGI Genomics Multiomics Introduction
11.10.4 BGI Genomics Revenue in Multiomics Business (2021–2026)
11.10.5 BGI Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Multiomics Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Single-cell Multiomics
Table 3. Key Players of Bulk Multiomics
Table 4. Global Multiomics Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Multiomics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Multiomics Market Size by Region (US$ Million), 2021–2026
Table 7. Global Multiomics Market Share by Region (2021–2026)
Table 8. Global Multiomics Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Multiomics Market Share by Region (2027–2032)
Table 10. Multiomics Market Trends
Table 11. Multiomics Market Drivers
Table 12. Multiomics Market Challenges
Table 13. Multiomics Market Restraints
Table 14. Global Multiomics Revenue by Players (US$ Million), 2021–2026
Table 15. Global Multiomics Market Share by Players (2021–2026)
Table 16. Global Top Multiomics Players by Tier (Tier 1, Tier 2, and Tier 3), based on Multiomics Revenue, 2025
Table 17. Ranking of Global Top Multiomics Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Multiomics Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Multiomics, Headquarters and Area Served
Table 20. Global Key Players of Multiomics, Products and Applications
Table 21. Global Key Players of Multiomics, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Multiomics Market Size by Type (US$ Million), 2021–2026
Table 24. Global Multiomics Revenue Market Share by Type (2021–2026)
Table 25. Global Multiomics Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Multiomics Revenue Market Share by Type (2027–2032)
Table 27. Global Multiomics Market Size by Application (US$ Million), 2021–2026
Table 28. Global Multiomics Revenue Market Share by Application (2021–2026)
Table 29. Global Multiomics Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Multiomics Revenue Market Share by Application (2027–2032)
Table 31. North America Multiomics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Multiomics Market Size by Country (US$ Million), 2021–2026
Table 33. North America Multiomics Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Multiomics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Multiomics Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Multiomics Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Multiomics Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Multiomics Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Multiomics Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Multiomics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Multiomics Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Multiomics Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Multiomics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Multiomics Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Multiomics Market Size by Country (US$ Million), 2027–2032
Table 46. BD Company Details
Table 47. BD Business Overview
Table 48. BD Multiomics Product
Table 49. BD Revenue in Multiomics Business (US$ Million), 2021–2026
Table 50. BD Recent Development
Table 51. Thermo Fisher Scientific, Inc. Company Details
Table 52. Thermo Fisher Scientific, Inc. Business Overview
Table 53. Thermo Fisher Scientific, Inc. Multiomics Product
Table 54. Thermo Fisher Scientific, Inc. Revenue in Multiomics Business (US$ Million), 2021–2026
Table 55. Thermo Fisher Scientific, Inc. Recent Development
Table 56. Illumina, Inc Company Details
Table 57. Illumina, Inc Business Overview
Table 58. Illumina, Inc Multiomics Product
Table 59. Illumina, Inc Revenue in Multiomics Business (US$ Million), 2021–2026
Table 60. Illumina, Inc Recent Development
Table 61. Danaher (Beckman Coulter) Company Details
Table 62. Danaher (Beckman Coulter) Business Overview
Table 63. Danaher (Beckman Coulter) Multiomics Product
Table 64. Danaher (Beckman Coulter) Revenue in Multiomics Business (US$ Million), 2021–2026
Table 65. Danaher (Beckman Coulter) Recent Development
Table 66. PerkinElmer, Inc Company Details
Table 67. PerkinElmer, Inc Business Overview
Table 68. PerkinElmer, Inc Multiomics Product
Table 69. PerkinElmer, Inc Revenue in Multiomics Business (US$ Million), 2021–2026
Table 70. PerkinElmer, Inc Recent Development
Table 71. Shimadzu Corporation Company Details
Table 72. Shimadzu Corporation Business Overview
Table 73. Shimadzu Corporation Multiomics Product
Table 74. Shimadzu Corporation Revenue in Multiomics Business (US$ Million), 2021–2026
Table 75. Shimadzu Corporation Recent Development
Table 76. Bruker Company Details
Table 77. Bruker Business Overview
Table 78. Bruker Multiomics Product
Table 79. Bruker Revenue in Multiomics Business (US$ Million), 2021–2026
Table 80. Bruker Recent Development
Table 81. QIAGEN Company Details
Table 82. QIAGEN Business Overview
Table 83. QIAGEN Multiomics Product
Table 84. QIAGEN Revenue in Multiomics Business (US$ Million), 2021–2026
Table 85. QIAGEN Recent Development
Table 86. Agilent Technologies, Inc. Company Details
Table 87. Agilent Technologies, Inc. Business Overview
Table 88. Agilent Technologies, Inc. Multiomics Product
Table 89. Agilent Technologies, Inc. Revenue in Multiomics Business (US$ Million), 2021–2026
Table 90. Agilent Technologies, Inc. Recent Development
Table 91. BGI Genomics Company Details
Table 92. BGI Genomics Business Overview
Table 93. BGI Genomics Multiomics Product
Table 94. BGI Genomics Revenue in Multiomics Business (US$ Million), 2021–2026
Table 95. BGI Genomics Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Multiomics Picture
Figure 2. Global Multiomics Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Multiomics Market Share by Type: 2025 vs 2032
Figure 4. Single-cell Multiomics Features
Figure 5. Bulk Multiomics Features
Figure 6. Global Multiomics Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Multiomics Market Share by Application: 2025 vs 2032
Figure 8. Cell Biology Case Studies
Figure 9. Oncology Case Studies
Figure 10. Neurology Case Studies
Figure 11. Immunology Case Studies
Figure 12. Others Case Studies
Figure 13. Multiomics Report Years Considered
Figure 14. Global Multiomics Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Multiomics Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Multiomics Market Share by Region: 2025 vs 2032
Figure 17. Global Multiomics Market Share by Players in 2025
Figure 18. Global Multiomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Multiomics Revenue in 2025
Figure 20. North America Multiomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Multiomics Market Share by Country (2021–2032)
Figure 22. United States Multiomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Multiomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Multiomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Multiomics Market Share by Country (2021–2032)
Figure 26. Germany Multiomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Multiomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Multiomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Multiomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Multiomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Multiomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Multiomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Multiomics Market Share by Region (2021–2032)
Figure 34. China Multiomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Multiomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Multiomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Multiomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Multiomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Multiomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Multiomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Multiomics Market Share by Country (2021–2032)
Figure 42. Mexico Multiomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Multiomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Multiomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Multiomics Market Share by Country (2021–2032)
Figure 46. Israel Multiomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Multiomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Multiomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. BD Revenue Growth Rate in Multiomics Business (2021–2026)
Figure 50. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Multiomics Business (2021–2026)
Figure 51. Illumina, Inc Revenue Growth Rate in Multiomics Business (2021–2026)
Figure 52. Danaher (Beckman Coulter) Revenue Growth Rate in Multiomics Business (2021–2026)
Figure 53. PerkinElmer, Inc Revenue Growth Rate in Multiomics Business (2021–2026)
Figure 54. Shimadzu Corporation Revenue Growth Rate in Multiomics Business (2021–2026)
Figure 55. Bruker Revenue Growth Rate in Multiomics Business (2021–2026)
Figure 56. QIAGEN Revenue Growth Rate in Multiomics Business (2021–2026)
Figure 57. Agilent Technologies, Inc. Revenue Growth Rate in Multiomics Business (2021–2026)
Figure 58. BGI Genomics Revenue Growth Rate in Multiomics Business (2021–2026)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed